A comprehensive clinical study of integrins in acute lymphoblastic leukemia indicates a role of α6/CD49f in persistent minimal residual disease and α5 in the colonization of cerebrospinal fluid

Leuk Lymphoma. 2020 Jul;61(7):1714-1718. doi: 10.1080/10428194.2020.1731500. Epub 2020 Feb 28.

Authors

Bibi Fatima Syed Shah Scharff¹, Signe Modvig¹, Maria Thastrup², Mette Levinsen², Matilda Degn², Lars Peter Ryder¹, Kjeld Schmiegelow^{3

2}, Claus Christensen¹, Hanne Vibeke Marquart¹

Affiliations

¹ Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
² Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
³ Department of Clinical Medicine, The Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.

PMID: 32107949
DOI: 10.1080/10428194.2020.1731500

No abstract available

Publication types

Letter

MeSH terms

Humans
Integrin alpha5
Integrin alpha6
Integrins*
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis

Substances

Integrin alpha5
Integrin alpha6
Integrins